Key Points
- Zyn gains traction in Trump world;
- RFK Jr. reportedly uses pouches;
- FDA adjusts enforcement policy;
- PMI says pouch business grew 36%.
2Firsts
May 19, 2026
According to The Wall Street Journal, nicotine pouch brand Zyn is rapidly gaining popularity across the Trump administration and conservative political circles in the United States, increasingly becoming a cultural symbol within the broader “MAGA” movement.
The report said nicotine pouches became a topic of discussion during a recent lunch between President Donald Trump and tobacco industry executives.
According to people familiar with the meeting, Trump called U.S. Health Secretary Robert F. Kennedy Jr. during the conversation and asked which nicotine pouch products he used, while expressing interest in the category.
Trump later told officials he wanted to see more nicotine pouch products authorized for sale, the report said.
Shortly afterward, the U.S. Food and Drug Administration (FDA) introduced a new policy stating that certain vaping and nicotine pouch products with completed PMTA applications would not face enforcement action before final scientific review is completed.
The FDA also said a pilot program launched in September 2025 to accelerate nicotine pouch product reviews had been progressing well.
White House spokesman Kush Desai said:
“The only guiding factor behind the Trump administration’s health policymaking is Gold Standard Science. FDA’s regulatory treatment of nicotine pouches is rooted in recent evidence that has found that nicotine pouches can help adults quit smoking.”
The Wall Street Journal said nicotine pouches have become one of the fastest-growing next-generation nicotine categories in the United States.
According to a 2025 study published in JAMA Network Open, nicotine pouches expanded from 4% of the U.S. oral tobacco and nicotine market in 2019 to 44% five years later.
Philip Morris International (PMI) told investors that its Zyn nicotine pouch business grew 36% in 2025.
The report said nicotine pouches are increasingly popular because they do not require combustion, produce no smoke, and can be used discreetly.
Within Trump-supporting and conservative political circles, Zyn has also evolved into a cultural and political symbol.
Some supporters jokingly adapted Dunkin’s advertising slogan “America Runs on Dunkin’” into “MAGA runs on Zyn.”
Former Fox News host Tucker Carlson was also credited with helping popularize Zyn among conservative audiences.
Appearing on a podcast in 2023, Carlson displayed a can of Zyn and said:
“You’ve gotta try this product, it’s unbelievable.”
He also described it as a “powerful work-enhancer.”
The report noted that nicotine pouch use has become especially common inside certain parts of the U.S. government.
At offices associated with Elon Musk’s Department of Government Efficiency (DOGE), cans of Zyn and rival brand Sesh were reportedly widespread.
At the General Services Administration (GSA), boxes of Sesh products were allegedly available for employees working extended hours.
One former administration official said:
“People are living on Celsius, Monster and Zyn.”
Besides Zyn, major nicotine pouch brands in the U.S. market include:
- Altria’s on!
- Reynolds American’s VELO
The report also said Kennedy has long supported nicotine pouch products.
In an interview with a Brazilian radio host last year, Kennedy said:
“Nicotine pouches are probably the safest way to consume nicotine.”
According to the report, Kennedy initially began using nicotine gum after being introduced to it by his wife, actress Cheryl Hines, during his presidential campaign to help him stay alert.
He later transitioned to nicotine pouch products.
The Wall Street Journal noted that although nicotine pouches are viewed by some consumers as lower-risk alternatives, public health experts continue raising concerns.
Experts warned that while nicotine pouches may carry lower risks than cigarettes and some vaping products, they may still:
- affect cardiovascular health;
- lead to nicotine dependence;
- and pose risks to adolescent brain development.
Former FDA tobacco regulator Mitch Zeller said:
“These products could be a huge help to addicted smokers who would be interested in switching to them, but the challenge is that some flavors may appeal to children.”
The report concluded that as traditional smoking rates continue declining in the United States, tobacco companies are increasingly shifting toward nicotine pouches, vaping products, and other reduced-risk alternatives in search of future growth.
（Cover Image：U.S. President Donald Trump looks at a container of Zyn nicotine pouches. ｜Image source: Saul Loeb / AFP / Getty Images / WSJ）
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
